186 related articles for article (PubMed ID: 23817086)
1. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.
Misumi Y; Ando Y; Gonçalves NP; Saraiva MJ
Lab Invest; 2013 Aug; 93(8):911-20. PubMed ID: 23817086
[TBL] [Abstract][Full Text] [Related]
2. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ
Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304
[TBL] [Abstract][Full Text] [Related]
3. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
4. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
[TBL] [Abstract][Full Text] [Related]
5. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
Teixeira AC; Saraiva MJ
J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Ferreira N; Saraiva MJ; Almeida MR
PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
[TBL] [Abstract][Full Text] [Related]
7. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
[TBL] [Abstract][Full Text] [Related]
8. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
[TBL] [Abstract][Full Text] [Related]
9. Activation of the heat shock response in familial amyloidotic polyneuropathy.
Santos SD; Magalhães J; Saraiva MJ
J Neuropathol Exp Neurol; 2008 May; 67(5):449-55. PubMed ID: 18431252
[TBL] [Abstract][Full Text] [Related]
10. Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy.
Santos SD; Cardoso I; Magalhães J; Saraiva MJ
J Pathol; 2007 Oct; 213(2):200-9. PubMed ID: 17724793
[TBL] [Abstract][Full Text] [Related]
11. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related.
Cardoso I; Brito M; Saraiva MJ
Dis Markers; 2008; 25(1):37-47. PubMed ID: 18776590
[TBL] [Abstract][Full Text] [Related]
13. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
Gonçalves P; Martins H; Costelha S; Maia LF; Saraiva MJ
Amyloid; 2016 Dec; 23(4):249-253. PubMed ID: 27884058
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
Cardoso I; Saraiva MJ
FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.
Suenaga G; Ikeda T; Komohara Y; Takamatsu K; Kakuma T; Tasaki M; Misumi Y; Ueda M; Ito T; Senju S; Ando Y
PLoS One; 2016; 11(10):e0163944. PubMed ID: 27695122
[TBL] [Abstract][Full Text] [Related]
17. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
[TBL] [Abstract][Full Text] [Related]
18. TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.
Moreira J; Martins H; Saraiva M; Saraiva MJ
Clin Sci (Lond); 2023 Mar; 137(5):355-366. PubMed ID: 36852978
[TBL] [Abstract][Full Text] [Related]
19. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin amyloid fibrils alter primary fibroblast structure, function, and inflammatory gene expression.
Dittloff KT; Iezzi A; Zhong JX; Mohindra P; Desai TA; Russell B
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H149-H160. PubMed ID: 34018852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
